Shire adhd webinar slides draft 040613

0 views
4,009 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
0
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Shire adhd webinar slides draft 040613

  1. 1. Shire ADHD Transitions Challenge Webinar Presentation Date: February 6th, 2013
  2. 2. On today s call: Tom Curatolo JL Neptune Jenn Stone Senior Director, Senior Vice President Challenge Manager Commercial Strategy Health 2.0 Health 2.0 Shire Pharmaceuticals
  3. 3. Agenda for Today s Meeting   Shire Pharmaceuticals Overview   ADHD Background   Challenge Goals   About the Phases   Evaluation Criteria   Timeline   Q & A
  4. 4. Shire Pharmaceuticals Focused Specialty Pharmaceutical Company   2011 Revenues of $4.3 billion   ~5,200 employees Specialty Human Genetic Regenerative Pharmaceuticals Therapies Medicine Chesterbrook, PA Lexington, MA San Diego, CA 66% 31% 3%
  5. 5. Shire Pharmaceuticals We unleash the potential of people affected by Behavioral Health Vision disorders by creating holistic solutions to help them lead better lives Priorities:   Better address unmet patient needs in ADHD   Diversify beyond Rx Therapy
  6. 6. Background   AboutAttention-Deficit/Hyperactivity Disorder (ADHD)   In the US, 9.5%* of children and 4.4%† of adults are affected by ADHD   Characterized by inattention, hyperactivity and impulsivity   Symptoms often manifest differently in adulthood (predominately inattention)   Patients navigate significant transitions during their journey to adulthood:   Relationships, school, work * Based on a 2007 survey of school-aged children (ages 4-17 years) who were reported by their parents to have ever been diagnosed with ADHD.† Based on a survey of US adults ages 18-44 years.
  7. 7. Challenge Goals   Areas to address   Transition from high-school to college   Transition from college to the workforce   Daily organizational and life management challenges   Connection with the healthcare system and encouragement of medication adherence
  8. 8. The Challenge   Phase I – Ideation   Submission requirements: concept mock-up and documentation   Awards: Five finalists awarded $5,000 each and continue to Phase II   Phase II – Development   Eligibility: Phase I finalist   Submission requirements: demo video, slide deck, and app (if provisional winner)   Awards: First Place $100,000, Second Place $20,000, Third Place $5,000
  9. 9. Evaluation Criteria   Phase I  Potential impact to improve the quality of life for application users.  Potential to connect users to health resources  Design, usability and intuitiveness of application  Creativity and innovation  Market potential and opportunity for commercialization
  10. 10. Evaluation Criteria   Phase II   Technical Development (i.e. Complexity and functionality of what was built)   Potential impact to improve the quality of life for application users.   Potential to connect users to health resources   Design, usability and intuitiveness of application   Creativity and innovation   Market potential and opportunity for commercialization
  11. 11. Timeline   Phase I submission phase ends: March 17, 2013   Phase II start: August 16, 2013   Phase II end: August 18, 2013   Winners announced: Health 2.0 Fall 2013 Conference September 30 - October 2
  12. 12. Questions? www.health2challenge.com Contact Jenn Stone at: jstone@health2con.com

×